about
Trial Watch:: Oncolytic viruses for cancer therapyCitrate Suppresses Tumor Growth in Multiple Models through Inhibition of Glycolysis, the Tricarboxylic Acid Cycle and the IGF-1R Pathway.How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells.Platelets and inflammatory markers in patients with gastric cancer.Molecular profiling of tumor-specific TH1 cells activated in vivo.The diverse roles of the TNF axis in cancer progression and metastasis.Rituximab efficiently depletes B cells in lung tumors and normal lung tissue.Type 1 Immune Mechanisms Driven by the Response to Infection with Attenuated Rabies Virus Result in Changes in the Immune Bias of the Tumor Microenvironment and Necrosis of Mouse GL261 Brain Tumors.Trial Watch: Anticancer radioimmunotherapy.Trial Watch: Radioimmunotherapy for oncological indications.Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages.Generation and Functional In Vitro Analysis of Semliki Forest Virus Vectors Encoding TNF-α and IFN-γ.Interleukin 10 expression is related to aggressiveness and poor prognosis of patients with thyroid cancer.Both Type I and Type II Interferons Can Activate Antitumor M1 Macrophages When Combined With TLR Stimulation
P2860
Q27021951-71D46E2E-0959-4032-992F-C8876FF1FA61Q33866783-0CEAC62A-9007-4530-8118-CC2C416CF412Q34418112-4BE24755-4DB5-4784-8379-6BBC1DE4D4ADQ36597474-5E93AC55-7494-4E0C-9C48-7932B720424FQ36716346-F3469724-F9B5-480F-9B4F-1CCF4A7ECBA7Q36887852-15D3E2C0-2666-4746-B363-2778393D47B6Q37474735-43518D03-0522-48F4-B258-E8E95C616217Q39680704-62272301-52E6-40FD-8900-A7D45519DF35Q40219738-91155602-575E-46EC-A7F7-CC11519449CBQ42847992-35A9CBC8-97B8-41C3-9CA4-65E5AEF88619Q43104064-5B8ED6B1-AC45-4945-9B05-AA0127AF0DBCQ45395222-5FCAA977-83C7-489C-BA9E-2B96C7647621Q47093975-84879049-8F12-4E6A-8EFF-2AE21FA53A40Q51321236-76A3EFBF-05E8-4A57-BB2D-8576C15EBAAFQ59132144-16BD4BCA-F68E-40F1-9EB1-E061B199A75D
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A model for cancer-suppressive inflammation
@en
type
label
A model for cancer-suppressive inflammation
@en
prefLabel
A model for cancer-suppressive inflammation
@en
P2860
P356
P1433
P1476
A model for cancer-suppressive inflammation
@en
P2093
Alexandre Corthay
Ole Audun Werner Haabeth
P2860
P304
P356
10.4161/ONCI.21542
P50
P577
2012-10-01T00:00:00Z